CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cytrx's Working Capital Ratio

CYTR's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CYTR Working Capital Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Current Liabilities Change 53.25 % -20.03 % -24.31 % -91.67 % -89.54 %
Y / Y Current Assets Change -25.35 % -23.59 % -37.53 % -53.51 % -48.91 %
Working Capital Ratio MRQ 7.37 8.39 9.08 21.69 15.13
Overall Ranking # # # # #
Seq. Current Liabilities Change 5.98 % -6.62 % 139.27 % -35.29 % -44.69 %
Seq. Current Assets Change -6.89 % -13.68 % 0.14 % -7.25 % -4.7 %



Working Capital Ratio first quarter 2020 Comment
Due to increase in Current Liabilities in the first quarter 2020, Working Capital Ratio fell to 7.37 below Cytrx Corp average.

Within Biotechnology & Drugs industry 67 other companies have achieved higher Working Capital Ratio than Cytrx in first quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is CYTR most successful ?
Working Capital Ratio CYTR on the trailing twelve month basis
Working Capital Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 68
Healthcare Sector # 202
Overall Market # 497


Working Capital Ratio Statistics
High Average Low
21.69 4.9 1.04
(Jun 30 2019)   (Jun 30 2012)




Financial Statements
Cytrx's Current Liabilities $ 2 Millions Visit CYTR's Balance sheet
Cytrx's Current Assets $ 16 Millions Visit CYTR's Balance sheet
Source of CYTR's Sales Visit CYTR's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Working Capital RatioMar 31 2020 MRQ Current AssetsMar 31 2020 MRQ Current Liabilities
Scpharmaceuticals Inc   18.64 $ 79.073  Millions$ 4.242  Millions
Adverum Biotechnologies Inc   17.92 $ 300.448  Millions$ 16.767  Millions
Repligen Corp  17.09 $ 651.378  Millions$ 38.106  Millions
Eidos Therapeutics Inc   16.97 $ 200.592  Millions$ 11.820  Millions
Crispr Therapeutics Ag  16.87 $ 929.282  Millions$ 55.086  Millions
Madrigal Pharmaceuticals Inc   16.13 $ 409.486  Millions$ 25.384  Millions
Enochian Biosciences Inc  15.98 $ 11.266  Millions$ 0.705  Millions
Organovo Holdings Inc   15.65 $ 28.318  Millions$ 1.810  Millions
Acceleron Pharma inc  15.15 $ 432.159  Millions$ 28.530  Millions
Satsuma Pharmaceuticals Inc   15.05 $ 108.879  Millions$ 7.233  Millions
Enzon Pharmaceuticals Inc   14.71 $ 6.237  Millions$ 0.424  Millions
Oxford Immunotec Global Plc  14.30 $ 200.716  Millions$ 14.032  Millions
Lixte Biotechnology Holdings Inc   14.14 $ 2.276  Millions$ 0.161  Millions
Oyster Point Pharma Inc   13.98 $ 131.018  Millions$ 9.374  Millions
Homology Medicines Inc   13.66 $ 238.333  Millions$ 17.452  Millions
Novavax Inc  13.45 $ 255.232  Millions$ 18.982  Millions
Cocrystal Pharma Inc   13.34 $ 22.582  Millions$ 1.693  Millions
Aerpio Pharmaceuticals Inc   13.33 $ 35.392  Millions$ 2.655  Millions
Pdl Biopharma Inc   13.21 $ 551.256  Millions$ 41.742  Millions
G1 Therapeutics Inc   13.20 $ 243.589  Millions$ 18.448  Millions
Neogen Corp  13.16 $ 514.875  Millions$ 39.135  Millions
Strongbridge Biopharma plc  12.86 $ 67.958  Millions$ 5.285  Millions
Denali Therapeutics Inc   12.70 $ 604.785  Millions$ 47.635  Millions
Halozyme Therapeutics Inc   12.32 $ 467.971  Millions$ 37.990  Millions
Assembly Biosciences inc   12.14 $ 256.752  Millions$ 21.146  Millions
Adma Biologics Inc   12.02 $ 165.488  Millions$ 13.765  Millions
89bio Inc   11.23 $ 87.413  Millions$ 7.787  Millions
Heska Corp  11.21 $ 245.660  Millions$ 21.906  Millions
Rapt Therapeutics Inc   10.93 $ 146.894  Millions$ 13.442  Millions
Axcella Health Inc   10.91 $ 76.821  Millions$ 7.040  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ZNGA's Profile

Stock Price

ZNGA's Financials

Business Description

Fundamentals

Charts & Quotes

ZNGA's News

Suppliers

ZNGA's Competitors

Customers & Markets

Economic Indicators

ZNGA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071